Allogene Therapeutics
ALLO
ALLO
169 hedge funds and large institutions have $301M invested in Allogene Therapeutics in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
-4
Holders Change %
-2.31%
% of All Funds
2.3%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
28
Increased
64
Reduced
41
Closed
30
Calls
$444K
Puts
$152K
Net Calls
+$292K
Net Calls Change
+$22K
Top Buyers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$16.2M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$7.84M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.09M |
| 4 |
Goldman Sachs
New York
|
+$5.47M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.04M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.9M |
| 2 |
State Street
Boston,
Massachusetts
|
-$6.51M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$3.2M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$986K |
| 5 |
Two Sigma Investments
New York
|
-$930K |
